Latest Daily News

Latest News
June 3, 2017

With appropriate oversight by regulatory authorities, professional organizations such as ASCO, and patient and clinician education programs, we will see the potential for considerable cost savings and increased access and equity of cancer care through the use of biosimilars.

Read more
June 3, 2017

The U.S. Food and Drug Administration will use real-world data from CancerLinQ® to help answer questions about the best use of emerging cancer treatments and inform future regulatory decision-making.

Read more

June 3, 2017

In 2015, ASCO and AACI led a multi-stakeholder survey to identify and prioritize the most burdensome regulatory and/or administrative aspects of clinical trials: clinical trial contracting, clinical trial coverage analyses and budgeting, and training and regulatory requirements.

Read more
June 2, 2017

Here are some bite-sized articles from Saturday's ASCO Daily News coverage.

Read more

June 2, 2017

Treating multiple myeloma in older patients presents specific challenges and requires certain considerations. 

Read more
June 2, 2017

During the 2017 ASCO Annual Meeting, more than $3 million will be provided to early-career physicians in support of their studies.

Read more
June 2, 2017

Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy at the Perelman School of Medicine, University of Pennsylvania, has been honored with the 2017 David A. Karnofsky Memorial Award.

Read more
June 2, 2017

ASCO remains dedicated to supporting the efforts of policymakers to strengthen the nation’s health care delivery system on behalf of all patients with cancer and their providers.

Read more

June 2, 2017

Dr. Siddhartha Mukherjee will serve as the guest speaker at this year’s Opening Session for the 2017 ASCO Annual Meeting.

Read more
June 2, 2017

Dr. Paulo M. G. Hoff, a member of ASCO’s Board of Directors, was elected to the National Academy of Medicine in October 2016.

Read more
June 2, 2017

Read Dr. John Sweetenham's letter to ASCO Daily News readers.

Read more

June 2, 2017

Utilization management is increasingly important in oncology care as oncology diagnosis and treatment has become more complex and expensive.

Read more
June 2, 2017

There is an urgent need to address disparities in the areas where the burden of HPV-related cancers is disproportionately high.

Read more
June 2, 2017

Researchers overseeing the trial at Roswell Park discuss the effectiveness of CIMAvax-EGF in NSCLC, the results of completed clinical trials in Cuba, and the long-term plans for additional testing of the vaccine.

Read more
June 2, 2017

Over the last year, CancerLinQ® announced official partnerships with a number of organizations that will comprise the CancerLinQ® Oncology Leadership Council.

Read more
June 2, 2017

Dr. Michael P. Link is the recipient of the 2017 Pediatric Oncology Award in recognition of his dedication to advancing the field of pediatric oncology by finding new strategies in the management of common childhood cancers. 

Read more
June 2, 2017

Dr. Susan L. Weiner founder and director of the Children’s Cause for Cancer Advocacy and long-time pediatric brain cancer advocate, is the recipient of the 2017 Partners in Progress Award. 

Read more
June 2, 2017

Dr. Ross C. Donehower is being honored with the 2017 ASCO Excellence in Teaching Award for his commitment to training future mentors.

Read more

June 2, 2017

Allen S. Lichter, MD, FASCO, said that being named the recipient of ASCO’s 2017 Distinguished Achievement Award feels like “a wonderful and unexpected surprise.”

Read more
June 2, 2017

Stephen A. Cannistra, MD, FASCO, editor-in-chief of the Journal of Clinical Oncology (JCO) and professor of medicine at Harvard Medical School, will speak about “The Peer-Review Process and Writing an Outstanding Manuscript."

Read more